April 2011
Volume 52, Issue 14
ARVO Annual Meeting Abstract  |   April 2011
Toll-like Receptor 4 Signaling Attenuates Experimental Allergic Conjunctivitis
Author Affiliations & Notes
  • Seong Hyun Choi
    Catholic University of Korea, Seoul, Republic of Korea
  • So-Hyang Chung
    Catholic University of Korea, Seoul, Republic of Korea
  • Kyong Jin Cho
    Catholic University of Korea, Seoul, Republic of Korea
  • Choun-Ki Joo
    Catholic University of Korea, Seoul, Republic of Korea
  • Footnotes
    Commercial Relationships  Seong Hyun Choi, None; So-Hyang Chung, None; Kyong Jin Cho, None; Choun-Ki Joo, None
  • Footnotes
    Support  This work was supported by the Korea Healthcare technology R & D Project, Ministry for Health, Welfare & Family Affairs, Republic of Korea. (A090136)
Investigative Ophthalmology & Visual Science April 2011, Vol.52, 1932. doi:
  • Views
  • Share
  • Tools
    • Alerts
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Seong Hyun Choi, So-Hyang Chung, Kyong Jin Cho, Choun-Ki Joo; Toll-like Receptor 4 Signaling Attenuates Experimental Allergic Conjunctivitis. Invest. Ophthalmol. Vis. Sci. 2011;52(14):1932.

      Download citation file:

      © ARVO (1962-2015); The Authors (2016-present)

  • Supplements

Purpose: : Allergic conjunctivitis from an allergen-driven Th2 response is characterized by conjunctival eosinophilic infiltration. Association between signaling through Toll-like receptor 4 (TLR4) and adaptive immune responses has been observed in allergic airway disease. We examined whether administration of bacterial LPS, a prototypic bacterial product that activates immune cells via the TLR4 could affect the development of allergic conjunctivitis and modify the immune response to ovalbumin (OVA) allergen in an experimental allergic conjunctivitis (EAC) model.

Methods: : Mice were challenged with two doses of OVA via conjunctival sac after systemic challenge with OVA in alum. Several indicators for allergy were evaluated in wild-type and TLR4-/- mice with or without adding of different doses of LPS into OVA in alum.

Results: : Mice challenged with OVA via conjunctival sac following systemic challenge with OVA in alum had severe allergic conjunctivitis. Of interest, LPS administration markedly suppressed IgE-mediated and eosinophil-dependent conjunctival inflammation. In addition, mice challenged with OVA had more IL-4, IL-5 and eotaxin secretion than mice in the non-inoculated group. The suppression of allergic response by LPS administration was due to Th1 shift. In contrast, inoculation of TLR4-/- mice with had no effect on severity of allergic conjunctivitis.

Conclusions: : Our findings demonstrate, for the first time, that LPS suppresses Th2 responses via the TLR4-dependent pathway in EAC model.

Keywords: conjunctiva • inflammation 

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.